Evidence map›Paper›PMID 40212049›Full record

ArticleEClinicalMedicine2025

Association between socioeconomic position and lung cancer incidence in 16 countries: a prospective cohort consortium study.

Justina Ucheojor Onwuka, Hana Zahed, Xiaoshuang Feng, Karine Alcala, Loretta Erhunmwunsee, Randi M Williams, Melinda C Aldrich, Jasjit S Ahluwalia, Demetrius Albanes, Alan A Arslan and 32 more

Abstract read
In one paragraph

Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

42 authors.

Justina Ucheojor OnwukaGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Hana ZahedGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Xiaoshuang FengGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Karine AlcalaGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Loretta ErhunmwunseeDivision of Thoracic Surgery, Department of Surgery, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Randi M WilliamsDepartment of Oncology, Cancer Prevention and Control Program, Lombardi Comprehensive Cancer Center, Georgetown University Medical Center, Washington, DC, USA.
Melinda C AldrichDepartment of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Jasjit S AhluwaliaCenter for Alcohol and Addiction Studies, Brown University School of Public Health and Alpert School of Medicine, Providence, RI, USA.
Demetrius AlbanesDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Alan A ArslanDepartments of Obstetrics and Gynecology and Population Health, New York University Grossman School of Medicine, New York, NY, USA.
Julie K BassettCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Paul BrennanGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Qiuyin CaiDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Chu ChenProgram in Epidemiology and the Women's Health Initiative Clinical Coordinating Center, Division of Public Health Sciences, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Niki DimouNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Pietro FerrariNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Neal D FreedmanDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Wen-Yi HuangDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Michael E JonesDivision of Genetics and Epidemiology, Institute of Cancer Research, London, United Kingdom.
Miranda R JonesDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Woon-Puay KohHealthy Longevity Translational Research Program, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore.
Arnulf LanghammerDepartment of Public Health and Nursing, HUNT Research Center, NTNU Norwegian University of Science and Technology, Levanger, Norway.
Linda M LiaoDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Reza MalekzadehDigestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Roger L MilneCancer Epidemiology Division, Cancer Council Victoria, Melbourne, Australia.
Thomas E RohanDepartment of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY, USA.
Maria-José SánchezEscuela Andaluza de Salud Pública, Granada, Spain.
Mahdi SheikhGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Rashmi SinhaDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Xiao-Ou ShuDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN, USA.
Victoria L StevensSocial and Scientific Systems, DLH Holdings Corporation, Atlanta, GA, USA.
Lesley F TinkerDivision of Public Health Sciences, Women's Health Initiative Clinical Coordinating Center, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Kala VisvanathanDivision of Cancer Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.
Ying WangAmerican Cancer Society, Atlanta, GA, USA.
Renwei WangUPMC Hillman Cancer Center, University of Pittsburgh, Pittsburgh, PA, USA.
Stephanie J WeinsteinDivision of Cancer Epidemiology and Genetics, National Cancer Institute, Rockville, MD, USA.
Emily WhiteCancer Prevention Research Program, Fred Hutchinson Cancer Center, Seattle, WA, USA.
Jian-Min YuanDepartment of Epidemiology, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, PA, USA.
Wei ZhengDivision of Epidemiology, Department of Medicine, Vanderbilt University Medical Center, Vanderbilt-Ingram Cancer Center, Nashville, TN, USA.
Mattias JohanssonGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.
Hilary A RobbinsGenomic Epidemiology Branch, International Agency for Research on Cancer, Lyon, France.

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI JOHN C. BYRD · 1988 to 2026
$158.0M
Prospective studies of cancer etiology and prevention in Shanghai and SingaporeR01CA144034 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2010 to 2014
$7.0M
THE SINGAPORE COHORT STUDY OF DIET AND CANCERR01CA080205 · NCI · UNIVERSITY OF SOUTHERN CALIFORNIA · PI YUAN, JIAN-MIN · 1999 to 2009
$5.3M
Cancer epidemiology cohorts in Shanghai and Singapore UM1CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2014 to 2018
$4.3M
The Lung EArly Proteins project: A LEAP toward implementing biomarkers in lung cancer screeningR01CA262164 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI ROBBINS, HILARY A. · 2022 to 2025
$2.0M
The Singapore Chinese Health StudyU01CA182876 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI YUAN, JIAN-MIN · 2019 to 2019
$150k
Evaluating risk prediction models for use in lung cancer screening in diverse populations around the worldR03CA245979 · NCI · INTERNATIONAL AGENCY FOR RES ON CANCER · PI ROBBINS, HILARY A. · 2020 to 2020
$112k
NCI NIH HHS P30 CA047904NCI NIH HHS R01 CA080205NCI NIH HHS R01 CA144034NCI NIH HHS R01 CA262164NCI NIH HHS R03 CA245979NCI NIH HHS U01 CA182876NCI NIH HHS UM1 CA182876World Health Organization 001
6 · The paper itself

Abstract

Background: Studies have reported higher lung cancer incidence among groups with lower socioeconomic position (SEP). However, it is not known how this difference in lung cancer incidence between SEP groups varies across different geographical settings. Furthermore, most prior studies that assessed the association between SEP and lung cancer incidence were conducted without detailed adjustment for smoking. Therefore, we aimed to assess this relationship across world regions. Methods: In this international prospective cohort consortium study, we used data from the Lung Cancer Cohort Consortium (LC3), which includes 20 prospective population cohorts from 16 countries in North America, Europe, Asia, and Australia. Participants were enrolled between 1985 and 2010 and followed for cancer outcomes using registry linkages and/or active follow-up. We estimated hazard ratios (HRs) for the association between educational level (our primary measure of SEP, in 4 categories) and incident lung cancer using Cox proportional hazards models separately for participants with and without a smoking history. The models were adjusted for age, sex, cohort (when multiple cohorts were included), smoking duration, cigarettes per day, and time since cessation. Findings: Among 2,487,511 participants, 53,830 developed lung cancer during a 13.5-year median follow-up (IQR = 6.5-15.0 years). Among participants with a smoking history, higher education was associated with decreased lung cancer incidence in nearly every cohort after detailed smoking adjustment. By world region, this association was observed in North America (HR per one-category increase in education [HR Interpretation: Based on longitudinal data from 2.5 million participants from 16 countries, our findings suggest that higher educational attainment was associated with lower lung cancer risk among participants with a smoking history, but not among participants who never smoked. Limitations of our study include that cohort participants cannot fully represent the general populations of the geographical regions included, and education was the only measure of SEP consistently available across our consortium. Funding: This study was supported in part by the National Cancer Institute (NCI), the Lung Cancer Research Foundation (LCRF), and the World Cancer Research Fund (WCRF).

Indexed as

Geographical differencesIncidenceLung cancerSocioeconomic position

Identifiers

PMID40212049
PMCPMC11985077

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.